EYE National Vision Holdings, Inc.
Ophthalmic Goods · Nasdaq · SEC CIK 1710155 · Fiscal year ends 01/02
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.0%
TTM net income YoY2,964.0%
TTM EPS YoY2,833.3%
Revenue 3-yr CAGR4.5%
Net income 3-yr CAGR—
Margins
Gross margin58.8%
Operating margin5.1%
Net margin3.2%
FCF margin3.3%
EBITDA margin9.6%
Returns
ROE7.5%
ROA3.3%
ROIC (approx.)7.2%
Asset turnover1.04x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.25x
Current ratio0.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.24x
Accruals ratio-4.1%
Payout ratio—
Capex / revenue3.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-10-03 | 2026Q22026-07-04 | 2026Q12026-04-04 | 2025Q4*2026-01-03 | 2025Q32025-09-27 | 2025Q22025-06-28 | 2025Q12025-03-29 | 2024Q42024-12-28 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $510.53M | $498.81M | $543.88M | $503.41M | $487.33M | $486.42M | $510.32M | $437.28M |
| Cost of revenue | $210.06M | $208.37M | $219.14M | $210.71M | $203.20M | $200.37M | $205.19M | $185.00M |
| Gross profit | $300.47M | $290.43M | $324.74M | $292.70M | $284.13M | $286.05M | $305.13M | $252.28M |
| SG&A expense | $247.13M | $243.43M | $256.09M | $261.21M | $252.34M | $247.17M | $255.53M | $233.05M |
| Operating income | $30.99M | $21.30M | $45.24M | $6.63M | $9.61M | $16.45M | $26.14M | -$25.57M |
| Pretax income | $28.00M | $17.96M | $42.39M | $2.39M | $5.49M | $12.24M | $21.57M | -$30.20M |
| Income tax | $8.81M | $5.55M | $11.21M | -$929,000 | $2.12M | $3.51M | $7.38M | -$758,000 |
| Net income | $19.19M | $12.42M | $31.18M | $3.32M | $3.37M | $8.72M | $14.19M | -$28.59M |
| EBITDA | $53.64M | $44.52M | $68.68M | $30.10M | $31.79M | $38.98M | $49.10M | -$2.83M |
| EPS (basic) | 0.24 | 0.16 | 0.39 | — | 0.04 | 0.11 | 0.18 | -0.36 |
| EPS (diluted) | 0.24 | 0.15 | 0.38 | — | 0.04 | 0.11 | 0.18 | -0.36 |
| Weighted avg. shares (diluted) | 80.06M | 80.60M | 81.49M | — | 81.19M | 80.06M | 79.26M | 78.75M |
| Balance sheet | ||||||||
| Cash & equivalents | $59.96M | $36.00M | $67.90M | $38.71M | $56.03M | $48.47M | $80.02M | $75.24M |
| Receivables | $40.98M | $34.90M | $43.99M | $57.32M | $46.13M | $45.96M | $53.17M | $49.94M |
| Inventory | $123.78M | $122.59M | $107.71M | $89.32M | $88.01M | $89.65M | $88.57M | $93.92M |
| Current assets | $256.24M | $226.88M | $260.62M | $225.72M | $220.19M | $217.70M | $254.12M | $249.83M |
| PP&E, net | $327.41M | $336.83M | $342.10M | $344.62M | $340.13M | $350.80M | $357.74M | $362.18M |
| Goodwill | $700.98M | $700.98M | $700.98M | $700.64M | $700.64M | $698.30M | $698.30M | $698.30M |
| Intangibles | $7.05M | $7.22M | $7.38M | $7.55M | $7.72M | $7.91M | $8.09M | $8.27M |
| Total assets | $2.00B | $1.98B | $2.02B | $1.98B | $1.96B | $1.97B | $2.01B | $2.01B |
| Current liabilities | $405.70M | $383.03M | $418.49M | $412.41M | $416.96M | $418.25M | $468.21M | $468.27M |
| Short-term debt | $13.25M | $13.25M | $13.25M | $13.25M | $13.25M | $13.25M | $98.02M | $98.02M |
| Long-term debt | $213.64M | $216.84M | $220.04M | $223.24M | $229.74M | $247.94M | $236.07M | $239.15M |
| Total debt | $226.89M | $230.09M | $233.29M | $236.49M | $242.99M | $261.19M | $334.10M | $337.17M |
| Total liabilities | $1.10B | $1.09B | $1.12B | $1.11B | $1.10B | $1.12B | $1.17B | $1.19B |
| Shareholders' equity | $901.17M | $897.00M | $898.01M | $869.53M | $858.76M | $850.58M | $836.16M | $816.33M |
| Net debt | $166.93M | $194.09M | $165.39M | $197.78M | $186.96M | $212.72M | $254.07M | $261.93M |
| Shares outstanding | 78.07M | 79.06M | 80.11M | 79.42M | 79.26M | 79.17M | 79.05M | 78.78M |
| Cash flow statement | ||||||||
| Operating cash flow | $65.06M | $8.11M | $61.70M | $13.16M | $46.63M | $54.26M | $32.24M | $30.28M |
| Capital expenditure | $15.72M | $22.20M | $17.57M | $24.40M | $16.37M | $11.85M | $20.23M | $32.02M |
| Free cash flow | $49.34M | -$14.09M | $44.14M | -$11.24M | $30.27M | $42.41M | $12.01M | -$1.74M |
| Investing cash flow | -$15.72M | -$16.49M | -$18.27M | -$24.32M | -$19.36M | -$12.70M | -$20.23M | -$33.73M |
| Financing cash flow | -$25.27M | -$23.90M | -$14.14M | -$6.11M | -$19.68M | -$73.42M | -$5.40M | -$3.99M |
| Depreciation & amortization | $22.65M | $23.22M | $23.44M | $23.47M | $22.18M | $22.54M | $22.96M | $22.75M |
| Stock-based compensation | $5.91M | $6.37M | $7.02M | $5.85M | $5.50M | $5.31M | $7.03M | $4.93M |
| Share buybacks | $21.40M | $20.08M | $10.52M | $650,000 | $876,000 | $55,000 | $1.62M | $273,000 |
Free plan shows the latest 8 periods; Pro shows all 43 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.